Publications

My publications cover the range of areas I have worked in, including the health economics of cancer care, occupational therapy rehabilitation and breast cancer clinical practice guidelines.

  1. Faaij M, Schoormans D, Pearce A. (2022). Work, daily activities and leisure after cancer. European Journal of Cancer Care. Early online.
  2. Christie L, Fearn N, McCluskey A, Lovarini M, Rendell R, Pearce A. (2022). Cost effectiveness of constraint induced movement therapy implementation in neurorehabilitation: The ACTIveARM Project. Pharmacoeconomics Open. Published online 22 March 2022*
  3. Goldsbury DE, Feletto E, Weber MF, Haywood P, Pearce A, Lew JB, Worthington J, He E, Steinberg J, O’Connell DL, Canfell K. (2022). Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PLOS One. 16(11):e0260088
  4. Hassett L, Jennings M, Brady B, Pinheiro M, Haynes A, Sidhu B, Christie L, Dennis S, Pearce A, Howard K, Greaves C & Sherrington C. (2022). Brief physical activity counselling by physiotherapists (BEHAVIOUR): protocol for an effectiveness-implementation hybrid type II cluster randomised controlled trial. Implementation Science Communications: 3(39)
  5. Sigurdson S, Harrison M, Pearce A, Richardson H, Zaza K, Brundage M. (2022). One fraction size does not fit all: Patient preferences for hypofractionated radiation therapy from a discrete choice experiment. Practical Radiation Oncology 12(1):e24-e33. 
  6. Marinovich L, Wylie E, Lotter W, Pearce A, Carter S, Lund H, Waddell A, Kim J, Pereira G, Lee C, Zackrisson S, Brennan M, Houssami N. (2022). Artificial intelligence (AI) to enhance breast cancer screening: protocol for a population-based cohort study of cancer detection. BMJ Open; 12 e054005.
  7. Goldsbury D, Feletto E, Weber M, Haywood P, Pearce A, Lew JB, Worthington J, He E, Steinberg J, O’Connell D, Canfell K. (2021). Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia. PLOS One. 16(11):e0260088
  8. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L. (2021). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4): 580-593
  9. Gelfand A, Sou J, Sawatzky R, Prescott K, Pearce A, Anis A H, Lee C, Zhang W. (2021). Valuation of lost productivity in caregivers: a validation study. Frontiers in Psychology (Organizational Psychology section). 12:727871. doi: 10.3389/fpsyg.2021.727871
  10. Williams J, Pearce A, Smith A. (2021). A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psycho-Oncology. 30( 8): 1185– 1195
  11. Yu A, Street D, Viney R, Goodall S, Pearce A, Haywood Ph, Haas M, Battaglini E, Goldstein D, Timmins H, Park S. (2021). Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences. Supportive Care in Cancer. 29, 6379–6387.
  12. Yim J, Shaw J, Viney R, Arora S, Ezendam N, Pearce A. (2021). Investigating the association between self-reported comorbid anxiety and depression and health service use in cancer survivors. Pharmacoeconomics. 39, pages681–690.
  13. Pearce A, Harrison M, Watson V, Street D, Howard K, Bansback N, Bryan S. (2021). Respondent understanding in discrete choice experiments: A scoping review. The Patient: 14, 17-53.
  14. Hanly P, Ortega Ortega M, Pearce A, Soerjomataram I, Sharp L. (2020). Advances in the methodological approach to friction period estimation: A European perspective. Social Science and Medicine: 264, p. 113289.
  15. Manipis K, Goodall S, Hanly P, Viney R, Pearce A (2020). Employer survey to estimate the productivity friction period. European Journal of Health Economics: 22: 255-266
  16. Mols F, Tomalin B, Pearce A, Kaambwa B, Koczwara B. (2020). Financial toxicity and employment status in cancer survivors. A systematic literature review. Supportive Care in Cancer: 28, 5693-5708
  17. Pearce A, Mulhern B, Watson V, Viney R. (2020). How are debriefing questions used in health discrete choice experiments? An online survey. Value in Health: 23(3), 289-293
  18. Smith A, Bamgboje-Ayodele A, Butow P, Klein B, Turner J, Sharpe L, Fardell J, Beatty L, Pearce A, Thewes B, Beith J, Costa D, Community Advisory Group Members and Girgis A. (2020). Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear). Psycho-Oncology:29(1),  
  19. Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, Anttila A, Auvinen A, Pearce A, Soerjomataram I. (2019). Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001-2030. Scandinavian Journal of Public Health: Early online. 
  20. Pearce A, Tomalin B, Kaambwa B, Horevoorts N, Duijts S, Mols F, van de Poll-Franse L, Koczwara B. (2018). Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors. Journal of Cancer Survivorship: Early online. 
  21. Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancel M, Gupta P, Meheus F, Qiao YL, Sitas F, Wang SM, Soerjomataram I (2018). Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China and South Africa (BRICS): A population-based comparison. Cancer Epidemiology: 53, 27-34.
  22. Shaw J, Pearce A, Lopez AL, Price M. (2018). Clinical anxiety disorders in the context of cancer: a scoping review of impact on resource use and health care costs. European Journal of Cancer Care, 27(5).
  23. Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, Ward R (2017). Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLOS One, 12(10): e0184360.
  24. Hanly P, Pearce A, Sharp L (2017). Cancer and productivity loss in the Irish economy: An employer’s perspective. Irish Journal of Management, 36(1): 5-20
  25. Thomas AA, Pearce A, O’Neill C, Molcho M, Sharp L. (2016). Urban-rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancer. Journal Epidemiology and Community Health.
  26. Pearce A, Bradley C, Hanly P, O’Neill C, Thomas AA, Molcho M, Sharp L. (2016). Projecting productivity losses for cancer-related mortality 2011 – 2030. BMC Cancer. 16:804
  27. Thomas AA, Pearce A, Sharp L, Gardiner RA, Chambers S, Aitken JA, Molcho M, Baade P. (2016). Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks. Asia-Pacific Journal of Clinical Oncology.
  28. Pearce A, Ryan F (joint first author), Drummond F, Thomas AA, Timmons A, Sharp L (2015). Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis. Supportive Care in Cancer. Early online 06 August 2015.
  29. Pearce A, Hanly P, Timmons A, Walsh PM, O’Neill C, O’Sullivan E, Gooberman-Hill R, Thomas AA, Gallagher P, Sharp L (2015). Productivity losses associated with head and neck cancer using the Human Capital and Friction Cost approaches. App Health Economics and Health Policy. Early online 19 February 2015.
  30. Pearce AM, Timmons A, O’Sullivan E, Gallagher P, Gooberman-Hill R, Thomas AA, Molcho M, Butow P, Sharp L (2015). Long-term workforce participation patterns following head and neck cancer. Journal of Cancer Survivorship, 9(1):30-39.
  31. Pearce A, Haas M, Viney R, Haywood P, Pearson SA, van Gool K, Srasuebkul P, Ward R (2014). Can administrative data be used to measure chemotherapy side effects? Expert Rev Pharmacoecon Outcomes Res. Early online 1-8.
  32. Sharp L, Deady S, Gallagher P, Molcho M, Pearce A, Thomas AA, Timmons A, Comber H (2014). The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer. 14:767
  33. Thomas AA, Gallagher P, O’Ceilleachair A, Pearce A, Sharp L, Molcho M (2014). Distance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysis. Supportive Care in Cancer. 23(3):741-751.
  34. Hanly P, Pearce AM, Sharp L (2014). The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Review of Pharmacoeconomics and Outcomes Research. 14(3), 355-377.
  35. Thomas AA, Timmons A, Molcho M, Pearce A, Gallagher P, Butow P, O’Sullivan E, Gooberman-Hill R, O’Neill C, Sharp L (2014). Quality of life in urban and rural settings: A study of head and neck cancer survivors. Oral Oncology. 50(7), 679-682.
  36. Pearce A, Haas M, Viney R (2013). Are the true impacts of adverse events considered in economic models of antineoplastic drugs? A systematic review. Journal of Applied Health Economics and Health Policy. 11(6), 619-637.
  37. Noushi F, Spillane AJ, Uren RF, Cooper R, Allwright S, Snook KL, Gillet D, Pearce A, Gebski V (2013). High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. European Journal of Surgical Oncology. 39(10), 1053-1060
  38. Pearce A, Van Gool K, Haywood P, Haas M (2013).  Delays in access to affordable medicines – putting policy into perspective: Authors’ response. Australian Health Review. 38(1), 16-17.
  39. Pearce A, Van Gool K, Haywood P, Haas M (2012).  Delays in access to affordable medicines – putting policy into perspective. Australian Health Review, 36(4), 412-418
  40. Pearce A, Smead J, Cameron I (2012).  Retrospective cohort study of accident outcomes for individuals who have successfully undergone driver assessment following stroke.  Australian Occupational Therapy Journal. 59(1), 56-62